R. Gregory Bociek

4.2k total citations
119 papers, 2.9k citations indexed

About

R. Gregory Bociek is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, R. Gregory Bociek has authored 119 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pathology and Forensic Medicine, 58 papers in Genetics and 42 papers in Oncology. Recurrent topics in R. Gregory Bociek's work include Lymphoma Diagnosis and Treatment (75 papers), Chronic Lymphocytic Leukemia Research (53 papers) and Viral-associated cancers and disorders (20 papers). R. Gregory Bociek is often cited by papers focused on Lymphoma Diagnosis and Treatment (75 papers), Chronic Lymphocytic Leukemia Research (53 papers) and Viral-associated cancers and disorders (20 papers). R. Gregory Bociek collaborates with scholars based in United States, Canada and Italy. R. Gregory Bociek's co-authors include Julie M. Vose, Jamés O. Armitage, Philip J. Bierman, Dennis D. Weisenburger, Wing C. Chan, Timothy C. Greiner, Lynette M. Smith, Christine P. Hans, Patricia Aoun and Anas Younes and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

R. Gregory Bociek

114 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Gregory Bociek United States	27	1.7k	1.3k	927	690	420	119	2.9k
Achiel Van Hoof Belgium	18	1.9k 1.2×	1.3k 1.0×	918 1.0×	375 0.5×	339 0.8×	33	2.6k
Loïc Ysebaert France	33	1.7k 1.0×	1.5k 1.1×	1.1k 1.2×	804 1.2×	1.2k 2.8×	139	3.7k
Chan Y. Cheah Australia	30	2.3k 1.4×	1.7k 1.3×	1.2k 1.3×	393 0.6×	441 1.1×	196	3.5k
Osnat Bairey Israel	27	1.4k 0.8×	598 0.5×	1.2k 1.3×	542 0.8×	486 1.2×	103	2.5k
Anne Sonet Belgium	22	1.3k 0.8×	873 0.7×	589 0.6×	285 0.4×	396 0.9×	64	2.2k
Frederick Hagemeister United States	27	2.3k 1.4×	1.7k 1.3×	1.0k 1.1×	488 0.7×	261 0.6×	69	3.3k
Stephen Opat Australia	25	1.7k 1.0×	980 0.7×	1.4k 1.5×	446 0.6×	562 1.3×	158	2.7k
Jonathon B. Cohen United States	23	1.7k 1.0×	1.6k 1.3×	725 0.8×	252 0.4×	579 1.4×	131	2.4k
Simon Rule United Kingdom	30	2.4k 1.5×	1.7k 1.3×	1.6k 1.7×	320 0.5×	519 1.2×	155	3.4k
Timothy S. Fenske United States	27	1.2k 0.7×	1.7k 1.3×	624 0.7×	435 0.6×	522 1.2×	162	2.6k

Countries citing papers authored by R. Gregory Bociek

Since Specialization

Citations

This map shows the geographic impact of R. Gregory Bociek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Gregory Bociek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Gregory Bociek more than expected).

Fields of papers citing papers by R. Gregory Bociek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Gregory Bociek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Gregory Bociek. The network helps show where R. Gregory Bociek may publish in the future.

Co-authorship network of co-authors of R. Gregory Bociek

This figure shows the co-authorship network connecting the top 25 collaborators of R. Gregory Bociek. A scholar is included among the top collaborators of R. Gregory Bociek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Gregory Bociek. R. Gregory Bociek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rana, Sandeep, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.. (2024). Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer Research Communications. 4(5). 1328–1343. 2 indexed citations

Vose, Julie M., Siddhartha Ganguly, Philip J. Bierman, et al.. (2023). Lenalidomide maintenance following high‐dose therapy and autologous haematopoietic stem cell transplantation in chemo‐resistant or high‐risk non‐Hodgkin lymphoma: A phase I/II study. British Journal of Haematology. 202(1). 116–121.

Schmit-Pokorny, Kim, Deborah A. Swanson, Valerie Shostrom, et al.. (2021). Assessment of Time to CAR-T Cell Therapy and Patients’ Outcomes in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Based on Insurance Status (Public Versus Private) and Distance Traveled to Treatment Center. Transplantation and Cellular Therapy. 27(3). S302–S303. 1 indexed citations

Johnson, Steven M., Yuan Ji, Yuri Fedoriw, et al.. (2018). Lymphomas with pseudo–double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations. Human Pathology. 80. 192–200. 23 indexed citations

Bhatt, Vijaya Raj, Smith Giri, Vivek Verma, et al.. (2016). Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database. Clinical Lymphoma Myeloma & Leukemia. 16(7). 373–378. 3 indexed citations

Bhatt, Vijaya Raj, Jagar Jasem, Smith Giri, et al.. (2015). Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 15(10). 606–611. 20 indexed citations

Bhatt, Vijaya Raj, Fausto R. Loberiza, Hongmei Jing, et al.. (2015). Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades. Clinical Lymphoma Myeloma & Leukemia. 15(7). 409–415.e1. 18 indexed citations

LaCasce, Ann S., R. Gregory Bociek, Jeffrey Matous, et al.. (2014). Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy. Blood. 124(21). 293–293. 20 indexed citations

Krishnamurthy, Jairam, et al.. (2014). Restrospective Review of Incidence, Complications and Management of Tumor Lysis Syndrome in High Risk Patients with Hematologic Malignancies. Blood. 124(21). 2621–2621. 1 indexed citations

10.

Loberiza, Fausto R., Anamarija M. Perry, Martin Bast, et al.. (2013). Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell/Histiocyte-Rich Large B-Cell Lymphoma?. Clinical Lymphoma Myeloma & Leukemia. 13(4). 392–397. 6 indexed citations

11.

Moskowitz, Craig H., Anas Younes, Sven de Vos, et al.. (2012). CSF1R Inhibition by PLX3397 in Patients with Relapsed or Refractory Hodgkin Lymphoma: Results From a Phase 2 Single Agent Clinical Trial. Blood. 120(21). 1638–1638. 23 indexed citations

12.

Vose, Julie M., Philip J. Bierman, Fausto R. Loberiza, et al.. (2012). Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation. 19(1). 123–128. 13 indexed citations

13.

Younes, Anas, Yasuhiro Oki, R. Gregory Bociek, et al.. (2011). Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial. The Lancet Oncology. 12(13). 1222–1228. 156 indexed citations

14.

Li, Wei, Javier A. Laurini, Philip J. Bierman, et al.. (2011). Sarcoidosis mimicking recurrent lymphoma. American Journal of Hematology. 87(7). 711–712. 4 indexed citations

15.

Bociek, R. Gregory, Fausto R. Loberiza, Philip J. Bierman, et al.. (2010). High-Dose Therapy (HDT) with Hematopoietic Stem Cell Transplantation (HSCT) Is Effective Therapy for Patients with Non-Hodgkin Lymphoma (NHL) and Central Nervous System (CNS) Involvement. Blood. 116(21). 1358–1358. 1 indexed citations

16.

Vose, Julie M., Dennis D. Weisenburger, Fausto R. Loberiza, et al.. (2010). Late relapse in patients with diffuse large B‐cell lymphoma. British Journal of Haematology. 151(4). 354–358. 15 indexed citations

17.

Fu, Kai, Kyle Perry, Lynette M. Smith, et al.. (2007). Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma. Journal of Clinical Oncology. 25(18_suppl). 8040–8040. 1 indexed citations

18.

Younes, Anas, Barbara Pro, Michelle A. Fanale, et al.. (2007). Isotype-Selective HDAC Inhibitor MGCD0103 Decreases Serum TARC Concentrations and Produces Clinical Responses in Heavily Pretreated Patients with Relapsed Classical Hodgkin Lymphoma (HL).. Blood. 110(11). 2566–2566. 26 indexed citations

19.

Panwalkar, Amit, Marcel P. Devetten, R. Gregory Bociek, & Alison G. Freifeld. (2006). Strategy for Managing Patients with Prior Invasive Aspergillosis through Allogeneic Transplant.. Blood. 108(11). 5318–5318. 1 indexed citations

20.

Pavletic, Steven Z., R. Gregory Bociek, James M. Foran, et al.. (2003). Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation1. Transplantation. 76(5). 877–881. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact